| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 65.23▲ | 64.08▲ | 64.05▲ | 60.06▲ | 59.11▲ |
| MA10 | 65.24▲ | 63.42▲ | 62.11▲ | 59.24▲ | 58.91▲ |
| MA20 | 64.38▲ | 61.58▲ | 60.55▲ | 57.20▲ | 49.61▲ |
| MA50 | 62.56▲ | 59.74▲ | 59.19▲ | 57.68▲ | 39.83▲ |
| MA100 | 60.52▲ | 59.06▲ | 58.24▲ | 47.35▲ | 24.35▲ |
| MA200 | 59.46▲ | 57.36▲ | 59.26▲ | 39.71▲ | 14.34▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.039▼ | 0.365▲ | 0.583▲ | 0.535▲ | 0.829▲ |
| RSI | 67.161▲ | 77.397▲ | 74.195▲ | 66.366▲ | 69.632▲ |
| STOCH | 67.859 | 87.338▲ | 92.688▲ | 61.190 | 60.381 |
| WILL %R | -14.224▲ | -5.528▲ | -4.577▲ | -2.261▲ | -14.583▲ |
| CCI | 49.463 | 122.403▲ | 143.447▲ | 275.666▲ | 96.216 |
|
Wednesday, November 26, 2025 04:04 AM
Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, announced ...
|
|
Tuesday, November 25, 2025 07:32 PM
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Organon (NYSE:OGN) and its peers. Looking ahead, the branded pharmaceutical industry ...
|
|
Tuesday, November 25, 2025 08:22 AM
Johnson & Johnson ends its Phase 2b posdinemab trial after missing key Alzheimer's goals, raising concerns for next-generation tau-targeting drug programs.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/11/25 | 60.92 | 65.84 | 59.01 | 65.53 | 91,517 |
| 24/11/25 | 59.05 | 60.89 | 59.00 | 60.47 | 89,900 |
| 21/11/25 | 57.32 | 60.215 | 56.65 | 58.59 | 255,786 |
| 20/11/25 | 58.29 | 60.40 | 57.11 | 57.44 | 92,584 |
| 19/11/25 | 57.51 | 59.39 | 57.01 | 58.29 | 118,700 |
| 18/11/25 | 57.11 | 59.91 | 57.11 | 57.73 | 201,800 |
| 17/11/25 | 57.83 | 60.81 | 57.115 | 58.00 | 222,238 |
| 14/11/25 | 57.29 | 60.425 | 56.27 | 57.89 | 206,703 |
| 13/11/25 | 60.42 | 61.8076 | 56.41 | 58.36 | 359,346 |
| 12/11/25 | 59.99 | 61.50 | 58.59 | 60.15 | 287,494 |
|
|
||||
|
|
||||
|
|